Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
803.91
707.49
666.53
647.21
687.33
754.46
676.84
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
803.91
707.49
666.53
647.21
687.33
754.46
676.84
Raw Material Cost
313.35
286.36
291.52
244.54
225.65
227.16
191.44
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
130.27
132.13
99.89
84.34
76.45
67.86
65.34
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.89
11.16
15.33
9.24
5.41
5.05
0.57
Selling and Distribution Expenses
261.28
241.95
201.09
234.88
260.64
319.69
312.47
Other Expenses
-9.15
-9.88
-7.01
-4.99
-4.27
-4.15
-3.65
Total Expenditure (Excl Depreciation)
617.33
572.83
537.77
523.07
525.41
578.27
533.34
Operating Profit (PBDIT) excl Other Income
186.6
134.70000000000002
128.8
124.1
161.9
176.20000000000002
143.5
Other Income
25.63
83.80
17.39
16.06
12.51
14.35
6.62
Operating Profit (PBDIT)
293.72
303.96
216.66
194.61
222.01
227.60
178.21
Interest
3.89
11.16
15.33
9.24
5.41
5.05
0.57
Exceptional Items
-4.30
-20.67
-6.85
-6.07
6.24
-7.11
-1.94
Gross Profit (PBDT)
490.56
421.13
375.00
402.67
461.67
527.29
485.40
Depreciation
94.79
96.73
78.79
63.22
55.83
48.79
22.80
Profit Before Tax
190.74
175.40
115.69
116.09
167.02
166.66
152.91
Tax
26.38
17.35
12.01
2.66
26.27
23.94
21.98
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
195.12
200.70
162.90
161.58
170.80
165.14
131.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
195.12
200.70
162.90
161.58
170.80
165.14
131.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.35
0.09
-0.85
-0.40
0.43
-0.19
-0.43
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
197.47
200.79
162.05
161.18
171.23
164.95
130.96
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,390.47
1,260.08
1,192.31
1,087.89
986.31
873.95
756.62
Earnings per share (EPS)
0.61
0.63
0.5
0.49
0.52
0.5
0.4
Diluted Earnings per share
0.61
0.63
0.5
0.49
0.52
0.5
0.4
Operating Profit Margin (Excl OI)
21.56%
17.45%
18.08%
17.82%
22.36%
21.8%
21.98%
Gross Profit Margin
35.52%
38.46%
29.18%
27.7%
32.42%
28.56%
25.96%
PAT Margin
24.27%
28.37%
24.44%
24.97%
24.85%
21.89%
19.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 13.63% vs 6.15% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -1.64% vs 23.95% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 21.75% vs 10.49% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -65.18% vs -26.80% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
803.91
0
803.91
Other Operating Income
0.00
0.00
0.00
Total Operating income
803.91
0
803.91
Raw Material Cost
313.35
0
313.35
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
130.27
0
130.27
Power Cost
0
0
0.00
Manufacturing Expenses
3.89
0
3.89
Selling and Distribution Expenses
261.28
0
261.28
Other Expenses
-9.15
0.00
-9.15
Total Expenditure (Excl Depreciation)
617.33
0
617.33
Operating Profit (PBDIT) excl Other Income
186.57
0.00
186.57
Other Income
25.63
0
25.63
Operating Profit (PBDIT)
293.72
0
293.72
Interest
3.89
0
3.89
Exceptional Items
-4.30
0
-4.30
Gross Profit (PBDT)
490.56
0
490.56
Depreciation
94.79
0
94.79
Profit Before Tax
190.74
0
190.74
Tax
26.38
0
26.38
Provisions and contingencies
0
0
0.00
Profit After Tax
195.12
0
195.12
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
195.12
0
195.12
Share in Profit of Associates
0
0
0.00
Minority Interest
2.35
0
2.35
Other related items
0.00
0.00
0.00
Consolidated Net Profit
197.47
0
197.47
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,390.47
0
1,390.47
Earnings per share (EPS)
0.61
0
0.61
Diluted Earnings per share
0.61
0
0.61
Operating Profit Margin (Excl OI)
21.56%
0%
0.00
21.56%
Gross Profit Margin
35.52%
0%
0.00
35.52%
PAT Margin
24.27%
0%
0.00
24.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 80.39 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 13.63% vs 6.15% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 19.75 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -1.64% vs 23.95% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.81 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 21.75% vs 10.49% in Dec 2024
Annual - Interest
Interest 0.39 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -65.18% vs -26.80% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.56%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






